Literature DB >> 15178703

Human neutrophils synthesize IL-8 in an IgE-mediated activation.

Javier Monteseirín1, Pedro Chacón, Antonio Vega, Rajaa El Bekay, Moisés Alvarez, Gonzalo Alba, Manuel Conde, Juan Jiménez, Juan A Asturias, Alberto Martínez, José Conde, Elizabeth Pintado, Francisco J Bedoya, Francisco Sobrino.   

Abstract

It has been demonstrated that neutrophils are responsible for the release of large amounts of the inflammatory chemokine interleukin-8 (IL-8), associated with inflammation. To further define the mechanisms implicated, we have analyzed the response of human neutrophils from allergic patients to specific antigens or challenge with anti-immunoglobulin (Ig)E antibodies. Neutrophils showed a dose- and time-dependent production of IL-8. The release of the cytokine was parallel to expression of IL-8 mRNA analyzed by the polymerase chain reaction. This expression was transient-it occurred after 3 h of anti-IgE treatment and was maintained for 18 h. Trifluoperazine, EGTA, reduced nicotinamide adenine dinucleotide phosphate-oxidase inhibitors, and reactive oxygen species (ROS) scavengers inhibited IL-8 production, indicating a critical dependence of calcium and oxidative stress. Moreover, an inhibitory effect of cyclosporin A, an immunosuppressor that inhibits calcineurin activity, on IL-8 release and IL-8 mRNA expression was observed. This is the first evidence of the involvement of ROS and calcium/calcineurin in IgE-dependent IL-8 production. These findings open new perspectives into the functional role of neutrophils in IgE-associated diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15178703     DOI: 10.1189/jlb.0903441

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  7 in total

1.  Local IgE and inflammation in chronic rhinosinusitis of asthmatics and non-asthmatics.

Authors:  Davor Vagic; Zeljko Ferencic; Petar Drvis; Goran Geber; Senka Dzidic; Tomislav Baudoin; Livije Kalogjera
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-26       Impact factor: 2.503

2.  Sputum neutrophil count after bronchial allergen challenge is related to peripheral blood neutrophil chemotaxis in asthma patients.

Authors:  Simona Lavinskiene; Ieva Bajoriuniene; Kestutis Malakauskas; Jolanta Jeroch; Raimundas Sakalauskas
Journal:  Inflamm Res       Date:  2014-09-12       Impact factor: 4.575

Review 3.  Reactive Oxygen Species in Venous Thrombosis.

Authors:  Clemens Gutmann; Richard Siow; Adam M Gwozdz; Prakash Saha; Alberto Smith
Journal:  Int J Mol Sci       Date:  2020-03-11       Impact factor: 5.923

4.  Features of Neutrophils From Atopic and Non-Atopic Elite Endurance Runners.

Authors:  Raquel Freitas Zambonatto; Renata Nakata Teixeira; Sarah de Oliveira Poma; Eliane Borges da Silva; Mariana Mendes de Almeida; Gerson Dos Santos Leite; Cesar Miguel Momesso Dos Santos; Heloisa Helena de Oliveira Alves; Renata Gorjão; Tania Cristina Pithon-Curi; Celso R F Carvalho; Rui Curi; Adriana Cristina Levada-Pires
Journal:  Front Immunol       Date:  2021-06-11       Impact factor: 7.561

5.  Regulation of the high affinity IgE receptor (Fc epsilonRI) in human neutrophils: role of seasonal allergen exposure and Th-2 cytokines.

Authors:  Martin P Alphonse; Arash S Saffar; Lianyu Shan; Kent T HayGlass; F Estelle R Simons; Abdelilah S Gounni
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

6.  Immunotherapy reduces allergen-mediated CD66b expression and myeloperoxidase levels on human neutrophils from allergic patients.

Authors:  Rocio Aroca; Cristina Chamorro; Antonio Vega; Inmaculada Ventura; Elisa Gómez; Ramón Pérez-Cano; Miguel Blanca; Javier Monteseirín
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

7.  fMLP-Induced IL-8 Release Is Dependent on NADPH Oxidase in Human Neutrophils.

Authors:  María A Hidalgo; María D Carretta; Stefanie E Teuber; Cristian Zárate; Leonardo Cárcamo; Ilona I Concha; Rafael A Burgos
Journal:  J Immunol Res       Date:  2015-11-08       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.